Home
About Us
In this Issue
Previous Issue
Editorial Board
How to Contribute
Advertise with Us
Editorial Calendar
Subcribe Now
Global Healthcare Releases provided by Business Wire

 The Publication & Databases on Biotechnology in the Asia Pacific
 
 More free   feature articles 
  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

EYE ON CHINA
Simulations Plus signs new partnership agreement in China

Simulations Plus, Inc., a leading provider of consulting services and software for pharmaceutical discovery and development, has signed a distributor agreement with the Research Institute for Liver Diseases (RILD) in Shanghai, People's Republic of China.

Mr. John DiBella, vice president for marketing and sales for Simulations Plus, said, "We're very pleased to be working with the RILD to offer in silico consulting services using our various software programs in support of RILD's in vitro experimental systems to its customers in China. Dr. Zhuohan Hu, President and CEO of RILD, is highly respected within the pharmaceutical industry in China, and we look forward to leveraging his connections with researchers at regulatory agencies and local companies to continue penetrating this growing market. We expect this new dealership to help promote our consulting services in the areas of drug absorption, toxicity, metabolism, and drug-drug interactions."

Source: Business Wire

Click here for the complete issue.


About Us | How to Contribute | How to Advertise With Us | Contact Us |

"The views expressed here does not necessarily reflect the views of Asia Pacific Biotech News or its staff."
Copyright © 2014 World Scientific Publishing Co. All rights reserved.